Charalambos Andreadis, Irit Avivi, Neta Goldschmidt, William Townsend, Mariana Bastos-Oreiro, Abraham Avigdor, Peter Riedell, Inna Tzoran, Toby Eyre, Pamela McKay, Pau Abrisqueta, Eva Gonzalez Barca, Alejandro Martin Garcia-Sancho, Sara Galimberti, Antonia Kwan, James Relf, Wilfred Leung, Francis Mussai, Connie Ma, Adrien Petel, Patrick Mueller, Xuefeng Hou, Christopher Fox. "Mosunetuzumab (Mosun) or glofitamab (Glofit) in combination with golcadomide (Golca) demonstrates a manageable safety profile and encouraging efficacy in patients with relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)." Blood, 2025. doi:10.1182/blood-2025-66